July 22, 2005

The European Commission's life sciences and biotechnology action plan includes an independent cost-benefit analysis of the "consequences, opportunities and challenges... of modern biotechnology" for Europe's economy, societies and environment.


You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments